Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.42 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.40 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.40 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.40 |
| ▸ | RRM1 | P23921 | 1/20 | 0.39 |
| ▸ | ALB | P02768 | 1/20 | 0.37 |
| ▸ | SPHK1 | Q9NYA1 | 3/20 | 0.34 |
| ▸ | NOD1 | Q9Y239 | 4/20 | 0.34 |
| ▸ | S1PR2 | O95136 | 2/20 | 0.33 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.33 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.33 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18148989 | 1.00 | DPP7 (0.42) | DPP7GNAI3GNAO1GNAI1RRM1 | |
| Hydrochloric Acid SCHEMBL27908684 | 0.99 | DPP7 (0.41) | DPP7GNAI3GNAO1GNAI1RRM1 | |
| Hydrochloric Acid SCHEMBL446666 | 0.99 | DPP7 (0.41) | DPP7GNAI3GNAO1GNAI1RRM1 | |
| Hydrochloric Acid SCHEMBL27686644 | 0.99 | DPP7 (0.41) | DPP7GNAI3GNAO1GNAI1RRM1 | |
| Hydrochloric Acid SCHEMBL3486209 | 0.99 | DPP7 (0.41) | DPP7GNAI3GNAO1GNAI1RRM1 | |
| SCHEMBL25364547 | 0.94 | EPHX2 (0.39) | DPP7GNAI3GNAO1GNAI1RRM1 | |
| SCHEMBL3975670 | 0.94 | EPHX2 (0.39) | DPP7GNAI3GNAO1GNAI1RRM1 | |
| SCHEMBL30130875 | 0.94 | EPHX2 (0.39) | DPP7GNAI3GNAO1GNAI1RRM1 | |
| SCHEMBL3975666 | 0.94 | EPHX2 (0.39) | DPP7GNAI3GNAO1GNAI1RRM1 | |
| Hydrochloric Acid SCHEMBL403392 | 0.93 | SLC6A5 (0.38) | DPP7GNAI3GNAO1GNAI1RRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105873568-A | Means for lung specific delivery | 赛伦斯治疗有限公司 | 2016-08-17 | — | — | CN | claimed |
| US-20190038557-A1 | MEANS FOR LUNG SPECIFIC DELIVERY | SILENCE THERAPEUTICS GMBH (DE) | 2019-02-07 | — | — | US | disclosed |
| CN-105873568-A | Means for lung specific delivery | 赛伦斯治疗有限公司 | 2016-08-17 | — | — | CN | disclosed |
| CN-1968714-B | Lipid, lipid complex and application thereof | SILENCE THERAPEUTICS AG | 2013-10-16 | — | — | CN | disclosed |
| CN-102940891-A | Lipids, lipid complexes and use thereof | ATUGEN AG | 2013-02-27 | — | — | CN | disclosed |
| CN-1968714-A | Lipid, lipid complex and application thereof | ATUGEN AG (DE) | 2007-05-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190038557-A1 | MEANS FOR LUNG SPECIFIC DELIVERY | SGMS1, SGMS2, DEGS1 | DPP7 3363/4885GNAI3 1545/4885GNAO1 4083/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.